Carregant...
One Year Experience of Pheburane(®) (Sodium Phenylbutyrate) Treatment in a Patient with Argininosuccinate Lyase Deficiency
Argininosuccinate lyase deficiency (ASLD) is a urea cycle disorder (UCD) treated with dietary adjustment and nitrogen scavenging agents. “Pheburane(®)” is a new tasteless and odour-free formulation of sodium phenylbutyrate, indicated in the treatment of UCD. A male patient diagnosed with ASLD was pu...
Guardat en:
| Publicat a: | JIMD Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501229/ https://ncbi.nlm.nih.gov/pubmed/25665834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2014_361 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|